In vitro evaluation of voriconazole against some clinically important fungi

Michael R. McGinnis; Lester Pasarell; Deanna A. Sutton; Annette W. Fothergill; Chester R. Cooper; Michael G. Rinaldi

doi:10.1128/aac.41.8.1832

In vitro evaluation of voriconazole against some clinically important fungi

Michael R. McGinnis, Lester Pasarell, Deanna A. Sutton, Annette W. Fothergill, Chester R. Cooper, Michael G. Rinaldi

Research output: Contribution to journal › Article › peer-review

110 Scopus citations

Abstract

Voriconazole was compared to amphotericin B, fluconazole, and itraconazole by using an in vitro macrobroth dilution test based upon current National Committee for Clinical Laboratory Standards tentative Standards against the dimorphic fungi and several opportunistic molds and yeasts. In all instances, the voriconazole MICs were lower than those of fluconazole. In most instances, the MICs were lower than the recorded MICs of amphotericin B and itraconazole.

Original language	English (US)
Pages (from-to)	1832-1834
Number of pages	3
Journal	Antimicrobial agents and chemotherapy
Volume	41
Issue number	8
DOIs	https://doi.org/10.1128/aac.41.8.1832
State	Published - Aug 1997

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)
Infectious Diseases

Access to Document

10.1128/aac.41.8.1832

Fingerprint Dive into the research topics of 'In vitro evaluation of voriconazole against some clinically important fungi'. Together they form a unique fingerprint.

Cite this

@article{bea5b866fa0644ce94ffb966d9d1793d,

title = "In vitro evaluation of voriconazole against some clinically important fungi",

abstract = "Voriconazole was compared to amphotericin B, fluconazole, and itraconazole by using an in vitro macrobroth dilution test based upon current National Committee for Clinical Laboratory Standards tentative Standards against the dimorphic fungi and several opportunistic molds and yeasts. In all instances, the voriconazole MICs were lower than those of fluconazole. In most instances, the MICs were lower than the recorded MICs of amphotericin B and itraconazole.",

author = "McGinnis, {Michael R.} and Lester Pasarell and Sutton, {Deanna A.} and Fothergill, {Annette W.} and Cooper, {Chester R.} and Rinaldi, {Michael G.}",

year = "1997",

month = aug,

doi = "10.1128/aac.41.8.1832",

language = "English (US)",

volume = "41",

pages = "1832--1834",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "8",

}

TY - JOUR

T1 - In vitro evaluation of voriconazole against some clinically important fungi

AU - McGinnis, Michael R.

AU - Pasarell, Lester

AU - Sutton, Deanna A.

AU - Fothergill, Annette W.

AU - Cooper, Chester R.

AU - Rinaldi, Michael G.

PY - 1997/8

Y1 - 1997/8

N2 - Voriconazole was compared to amphotericin B, fluconazole, and itraconazole by using an in vitro macrobroth dilution test based upon current National Committee for Clinical Laboratory Standards tentative Standards against the dimorphic fungi and several opportunistic molds and yeasts. In all instances, the voriconazole MICs were lower than those of fluconazole. In most instances, the MICs were lower than the recorded MICs of amphotericin B and itraconazole.

AB - Voriconazole was compared to amphotericin B, fluconazole, and itraconazole by using an in vitro macrobroth dilution test based upon current National Committee for Clinical Laboratory Standards tentative Standards against the dimorphic fungi and several opportunistic molds and yeasts. In all instances, the voriconazole MICs were lower than those of fluconazole. In most instances, the MICs were lower than the recorded MICs of amphotericin B and itraconazole.

UR - http://www.scopus.com/inward/record.url?scp=0030744632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030744632&partnerID=8YFLogxK

U2 - 10.1128/aac.41.8.1832

DO - 10.1128/aac.41.8.1832

M3 - Article

C2 - 9257773

AN - SCOPUS:0030744632

VL - 41

SP - 1832

EP - 1834

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 8

ER -